| Accession Number: | 0000899243-22-013858 |
| Date: | 2022-04-01 |
| Issuer: | VIRIDIAN THERAPEUTICS, INC.\DE (VRDN) |
| Original Submission Date: |
VIOLIN JONATHAN
C/O VIRIDIAN THERAPEUTICS, INC.
221 CRESCENT STREET, SUITE 401
WALTHAM, MA 02453
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2022-04-01 | S | 26,400 | d | $18.92 | 544,505 | direct | ||
| COMMON STOCK | 2022-04-04 | S | 3,600 | d | $18.93 | 540,905 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | this transaction was executed pursuant to a rule 10b5-1 trading plan in multiple trades at prices ranging from $18.34 to $19.43. the price reported above reflects the weighted average sales price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| f2 | this transaction was executed pursuant to a rule 10b5-1 trading plan in multiple trades at prices ranging from $18.64 to $19.16. the price reported above reflects the weighted average sales price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
